In 2007, HIV drugs generated sales of $9.3 billion across the seven major markets (7MM), expanding with a compound annual growth rate (CAGR) of 11.3% (2004-2007). Over the next 10 years a new report expects the market’s growth to slow down somewhat, but still reach total sales of $15.1 billion in 2017.

Continue reading “Battle for HIV drug market share getting fiercer – maybe too fierce for some” »